Hofseth BioCare ASA Statistics

Total Valuation

Hofseth BioCare ASA has a market cap or net worth of NOK 707.06 million. The enterprise value is 878.58 million.

Market Cap	707.06M
Enterprise Value	878.58M

Important Dates

The next estimated earnings date is Friday, February 14, 2025.

Earnings Date	Feb 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Hofseth BioCare ASA has 411.08 million shares outstanding. The number of shares has increased by 2.97% in one year.

Current Share Class	n/a
Shares Outstanding	411.08M
Shares Change (YoY)	+2.97%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.97%
Owned by Institutions (%)	21.66%
Float	269.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.82
PB Ratio	6.81
P/TBV Ratio	7.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.58
EV / Sales	3.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.74

Financial Position

The company has a current ratio of 0.73, with a Debt / Equity ratio of 1.90.

Current Ratio	0.73
Quick Ratio	0.30
Debt / Equity	1.90
Debt / EBITDA	n/a
Debt / FCF	-3.28
Interest Coverage	-10.24

Financial Efficiency

Return on equity (ROE) is -135.42% and return on invested capital (ROIC) is -29.87%.

Return on Equity (ROE)	-135.42%
Return on Assets (ROA)	-19.16%
Return on Capital (ROIC)	-29.87%
Revenue Per Employee	3.54M
Profits Per Employee	-1.91M
Employee Count	71
Asset Turnover	0.65
Inventory Turnover	2.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.74% in the last 52 weeks. The beta is 0.34, so Hofseth BioCare ASA's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	-40.74%
50-Day Moving Average	1.42
200-Day Moving Average	1.87
Relative Strength Index (RSI)	62.10
Average Volume (20 Days)	237,211

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hofseth BioCare ASA had revenue of NOK 248.08 million and -133.48 million in losses. Loss per share was -0.33.

Revenue	248.08M
Gross Profit	60.36M
Operating Income	-117.60M
Pretax Income	-133.48M
Net Income	-133.48M
EBITDA	-102.72M
EBIT	-117.60M
Loss Per Share	-0.33

Full Income Statement

Balance Sheet

The company has 23.38 million in cash and 195.58 million in debt, giving a net cash position of -172.21 million or -0.42 per share.

Cash & Cash Equivalents	23.38M
Total Debt	195.58M
Net Cash	-172.21M
Net Cash Per Share	-0.42
Equity (Book Value)	103.07M
Book Value Per Share	0.25
Working Capital	-47.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -59.38 million and capital expenditures -227,000, giving a free cash flow of -59.61 million.

Operating Cash Flow	-59.38M
Capital Expenditures	-227,000
Free Cash Flow	-59.61M
FCF Per Share	-0.15

Full Cash Flow Statement

Margins

Gross margin is 24.33%, with operating and profit margins of -47.40% and -53.80%.

Gross Margin	24.33%
Operating Margin	-47.40%
Pretax Margin	-53.80%
Profit Margin	-53.80%
EBITDA Margin	-41.40%
EBIT Margin	-47.40%
FCF Margin	n/a

Dividends & Yields

Hofseth BioCare ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.97%
Shareholder Yield	-2.97%
Earnings Yield	-19.09%
FCF Yield	-8.43%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a